 |
市場調查報告書
商品編碼
1349985
白血球消除設備市場:各設備類型，各用途，各終端用戶，各地區:市場規模，佔有率，展望，機會分析，2023年～2030年Leukapheresis Devices Market, By Device Type, By Application, By End User, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 |
||||||
2023年全球白血球分離設備市場規模預估為2,990萬美元，預測期間內（2023-2030年）複合年增長率為7.9%。
| 報告範圍 | 報告詳細資料 | ||
|---|---|---|---|
| 基準年 | 2022 | 2023 年市場規模 | 2990萬美元 |
| 過去的資料 | 2018年至2021年 | 預測期間 | 2023-2030 |
| 預測 2023-2030 年複合年增長率： | 7.90% | 2030年價值預測 | 5,100萬美元 |
白血病是一種從血液樣本中分離白血球的醫療程序。進行此手術是為了減少血液惡性腫瘤患者的白血球數量。因此，白血球分離機是一種用於促進此過程的醫療設備。臨床研究中白血球檢測需求的不斷增長是推動市場成長的主要因素之一。與捐血相關的活動越來越多，加上技術創新和進步不斷增加，也是市場成長的決定因素。個人健康意識的提高、對白血球（WBC）分離過程的認可度提高以及醫療旅遊業的興起是創造進一步利潤豐厚的市場成長機會的其他關鍵因素。
市場動態
這份全球白血球去除設備市場報告涵蓋了最新發展、貿易法規、進出口分析、生產分析、價值鏈優化、市場佔有率、國家和本地市場參與者的影響、新收入來源從市場監管的角度進行分析變化、策略市場成長分析、市場規模、類別市場成長、應用利基和優勢、產品批准、產品發布、區域市場分析以及市場技術創新的詳細資訊。例如，2021 年 12 月，正在開發突破性醫療器材以解決血流感染治療中未滿足的臨床需求的 ExThera Medical 宣布，旭化成集團有限公司的核心營運公司旭化成醫療公司已與旭化成醫療公司簽署合作協議。 ExThera 的Seraph 100 Microbind 親和血液過濾器(Seraph 100) 在日本的獨家經銷協議。根據該協議，ExThera Medical 和旭化成醫療有限公司將共同努力獲得 Seraph 100 在日本的上市許可。由於白血病盛行率不斷增加，全球白血球分離設備市場預計在預測期內將顯著增長。例如，2022 年 6 月，Terumo Blood 專門從事血液成分採集、治療性單採和細胞技術，而 Cell Technologies 專門從事血液成分採集、治療性單採和細胞技術的產品、軟體和服務組合。該公司與領先的醫療技術公司、BioBridge Global 的子公司GenCure 簽訂了一項新的合作協議，以擴展和統一細胞和基因治療製造解決方案。
本調查的主要特徵
- 本報告提供以2022年為基準年的預測期間（2023-2030 年）之全球白血球消除設備市場的市場規模和復合年增長率（CAGR %）相關的詳區隔析。
- 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
- 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
- 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球白血球消除設備市場的主要參與者之企業簡介。
- 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
- 全球白血球消除設備市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
- 利益相關者可以透過全球白血球消除設備市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。
目錄
第1章 調查目的與前提條件
- 調查目的
- 前提條件
- 簡稱
第2章 市場概況
- 報告概要
- 市場定義和範圍
- 摘要整理
- Coherent Opportunity Map(COM)
第3章 市場動態，法規，趨勢分析
- 市場動態
- 促進因素
- 阻礙因素
- 市場機會
- 影響分析
- 最近的產品上市
- 流行病學
- 合併，收購，聯盟
- 法規情勢
- 主要的發展
- PEST分析
第4章 白血球消除設備的全球市場:COVID-19影響分析
- 經濟影響
- COVID-19流行病學
- 供需的影響
第5章 白血球消除設備的全球市場:各設備類型，2018-2030年
- 單採設備
- 白血球消除管柱及細胞分離器
- 白血球消除過濾器
- 白血球分離術拋棄式
第6章 白血球消除設備的全球市場:各用途，2018-2030年
- 調查用途
- 治療用途
第7章 白血球消除設備的全球市場:各終端用戶，2018-2030年
- 醫院
- 學術·研究機關
- 製藥·生物科技企業
- 血液成分供應商
- 血液中心
第8章 白血球消除設備的全球市場:各地區，2018-2030年
- 北美
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 南美
- 巴西
- 墨西哥
- 阿根廷
- 其他南美國家
- 中東
- GCC
- 以色列
- 其他中東
- 非洲
- 北非
- 中非
- 南非
- 其他非洲國家
第9章 企業簡介
- Asahi Kasei Medical Co. Ltd.
- 產品系列
- 主要的焦點
- 業績
- 策略
- Haemonetics Corporation
- 產品系列
- 主要的焦點
- 業績
- 策略
- Terumo BCT Inc.
- 產品系列
- 主要的焦點
- 業績
- 策略
- STEMCELL Technologies Inc.
- 產品系列
- 主要的焦點
- 業績
- 策略
- Fresenius SE & Co. KGaA
- 產品系列
- 主要的焦點
- 業績
- 策略
- BioIVT
- 產品系列
- 主要的焦點
- 業績
- 策略
- Grifols, S.A
- 產品系列
- 主要的焦點
- 業績
- 策略
- HemaCare
- 產品系列
- 主要的焦點
- 業績
- 策略
- Braun Melsungen AG
- 產品系列
- 主要的焦點
- 業績
- 策略
- Caltag Medsystems Limited
- 產品系列
- 主要的焦點
- 業績
- 策略
- AllCells
- 產品系列
- 主要的焦點
- 業績
- 策略
- StemExpress
- 產品系列
- 主要的焦點
- 業績
- 策略
- PPA
- 產品系列
- 主要的焦點
- 財務效能
- 策略
- Cellero
- 產品系列
- 主要的焦點
- 財務效能
- 策略
- Precision for Medicine, Inc
- 產品系列
- 主要的焦點
- 業績
- 策略
- The Intelligent Tissue Group Lonza
- 產品系列
- 主要的焦點
- 業績
- 策略
- Lmb Technologie GmbH
- 產品系列
- 主要的焦點
- 業績
- 策略
- Kaneka Medical Europe N.V.
- 產品系列
- 主要的焦點
- 業績
- 策略
- Key Biologics, LLC.
- 產品系列
- 主要的焦點
- 業績
- 策略
第10章 章節
- 分析師的見解
- 參考文獻
- 調查手法
The global leukapheresis devices market is estimated to be valued at US$ 29.9 Million in 2023 and is expected to exhibit a CAGR of 7.9% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 29.9 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 7.90% | 2030 Value Projection: | US$ 51 Mn |
Leukaemia is a medical procedure that involves separating white blood cells from a sample of blood. The procedure is undergone to reduce the quantity of white blood cells in patients wuth hematological malignancies. Therefore, leukapheresis devices are the medical devices that are used to facilitate this procedure. The surge in demand for leukopaks in clinical research is one of the major factors fostering the growth of the market. Growth in the number of activities associated with blood donations coupled with growing innovations and advancements in technologies is another market growth determinant. Rising health awareness among individuals, growing approvals for processes of isolating white blood cells (WBC), and rising medical tourism are other important factors that will further generate lucrative market growth opportunities.
Market Dynamics
This global leukapheresis devices market report provides details of recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. For instance, In December 2021, ExThera Medical develops revolutionary medical devices that address unmet clinical needs in the treatment of bloodstream infections and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, entered into an exclusive distribution agreement in Japan for ExThera's Seraph 100 Microbind Affinity Blood Filter (Seraph 100). As per the agreement structure, ExThera Medical and Asahi Kasei Medical will collaborate to obtain regulatory approval for Seraph 100 for commercialization in Japan. The global leukapheresis devices market is expected to witness significant growth during the forecast period, owing to the increasing prevalence of leukemia. For instance, in June 2022, Terumo Blood is in blood component, therapeutic apheresis and cellular technologies and Cell Technologies, a medical technology company specializing in a portfolio of products, software, and services for blood component collection, therapeutic apheresis, and cellular technologies, announced it had signed a new collaborative agreement with GenCure, a subsidiary of BioBridge Global, to extend and unify cell and gene therapy manufacturing solutions.
Key features of the study:
- This report provides an in-depth analysis of the global leukapheresis devices market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global leukapheresis devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, HemaCare, B. Braun Melsungen AG, Caltag Medsystems Limited, AllCells, StemExpress, PPA, Cellero, Precision for Medicine, Inc., The Intelligent Tissue Group Lonza, BioIVT, Lmb Technologie GmbH, Kaneka Medical Europe N.V. and Key Biologics, LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding its future product launches, type up-gradation, market expansion, and marketing tactic
- The global leukapheresis devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukapheresis devices market
Detailed Segmentation:
- Global Leukapheresis Devices Market, By Device Type:
- Apheresis Devices
- Leukapheresis Columns & Cell Separators
- Leukoreduction Filters
- Leukapheresis Disposables
- Global Leukapheresis Devices Market, By Application :
- Research Applications
- Therapeutic Applications
- Global Leukapheresis Devices Market, By End User:
- Hospitals
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Blood Component Providers
- Blood Centers
- Global Leukapheresis Devices Market , By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Asahi Kasei Medical Co. Ltd.
- Haemonetics Corporation
- Terumo BCT Inc.
- STEMCELL Technologies Inc.
- Fresenius SE & Co. KGaA
- BioIVT, Grifols, S.A
- HemaCare
- B.Braun Melsungen AG
- Caltag Medsystems Limited
- AllCells
- StemExpress
- PPA
- Cellero
- Precision for Medicine, Inc.
- The Intelligent Tissue Group Lonza
- BioIVT
- Lmb Technologie GmbH
- Kaneka Medical Europe N.V.
- Key Biologics, LLC.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Leukapheresis Devices Market- COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Leukapheresis Devices Market, By Device Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Apheresis Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Leukapheresis Columns & Cell Separators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Leukoreduction Filters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Leukapheresis Disposables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
6. Global Leukapheresis Devices Market, By Application, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Therapeutic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
7. Global Leukapheresis Devices Market, By End User, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Blood Component Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Blood Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
8. Global Leukapheresis Devices Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- North America
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2018-2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Rest of Africa
9. Company Profiles
- Asahi Kasei Medical Co. Ltd.*
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Haemonetics Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Terumo BCT Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- STEMCELL Technologies Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fresenius SE & Co. KGaA
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioIVT
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Grifols, S.A
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- HemaCare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Braun Melsungen AG
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Caltag Medsystems Limited
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AllCells
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- StemExpress
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PPA
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cellero
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Precision for Medicine, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- The Intelligent Tissue Group Lonza
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lmb Technologie GmbH
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kaneka Medical Europe N.V.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Key Biologics, LLC.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
10. Section
- Analyst view
- References
- Research Methodology
About us and Sales Contact*Browse 36 market data tables and 33 figures on "Leukapheresis Devices Market "- Global Forecast to 2030
